Figure 14.
Antiangiogenic effect of SN38, active metabolite of CPT11. Low dose of SN38 (0.01 and 0.1 μM) inhibited tube formation of HUVEC.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.